{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:41:53Z","timestamp":1784950913117,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025010","name":"Dipartimento di Scienze del Farmaco, Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["41451.32"],"award-info":[{"award-number":["41451.32"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117725","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:35:11Z","timestamp":1768894511000},"page":"117725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neurophysiological and neuropharmacological effects of melatonin MT2 receptors activation in MK-801-induced schizophrenia-like dysfunctions"],"prefix":"10.1016","volume":"246","author":[{"given":"Benedetta","family":"Barzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Marchiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Casile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cifani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pitsikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cambiaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-7194","authenticated-orcid":false,"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7321","key":"10.1016\/j.bcp.2026.117725_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"Suppl 9","key":"10.1016\/j.bcp.2026.117725_b0010","first-page":"3","article-title":"Cognitive impairment and functional outcome in schizophrenia and bipolar disorder","volume":"67","author":"Green","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.bcp.2026.117725_b0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0020","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1002\/pcn5.13","article-title":"The pharmacological treatment of schizophrenia: how far have we come?","volume":"1","author":"Rubio","year":"2022","journal-title":"PCN Rep"},{"issue":"8","key":"10.1016\/j.bcp.2026.117725_b0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamapsychiatry.2024.0785","article-title":"Efficacy and safety of xanomeline-trospium chloride in schizophrenia: a randomized clinical trial","volume":"81","author":"Kaul","year":"2024","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/appi.ajp.20240076","article-title":"The impact of xanomeline and trospium chloride on cognitive impairment in acute schizophrenia: replication in pooled data from two phase 3 trials","volume":"182","author":"Horan","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2026.117725_b0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bcp.2026.117725_b0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.apha.2016.01.006","article-title":"The NMDA receptor and schizophrenia: from pathophysiology to treatment","volume":"76","author":"Balu","year":"2016","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117725_b0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnmol.2019.00185","article-title":"NMDAR hypofunction animal models of schizophrenia","volume":"12","author":"Lee","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2026.117725_b0055","article-title":"The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability","volume":"15","author":"Mercuriali","year":"2024","journal-title":"Front. Psych."},{"key":"10.1016\/j.bcp.2026.117725_b0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pnpbp.2012.12.021","article-title":"Sleep and circadian rhythm dysregulation in schizophrenia","volume":"43","author":"Monti","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1192\/bjp.bp.111.096321","article-title":"Sleep and circadian rhythm disruption in schizophrenia","volume":"200","author":"Wulff","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2026.117725_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41398-020-0694-0","article-title":"Circadian rhythm disruption and mental health","volume":"10","author":"Walker","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.bcp.2026.117725_b0075","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.13011","article-title":"Melatonin, melatonin receptors and sleep: moving beyond traditional views","volume":"76","author":"Comai","year":"2024","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11011-019-00395-3","article-title":"Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia","volume":"34","author":"Sahbaz","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(94)91147-9","article-title":"Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia","volume":"35","author":"Rao","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0095","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12952","article-title":"Melatonin receptor structure and signaling","volume":"76","author":"Okamoto","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2026.117725_b0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fendo.2019.00087","article-title":"Differential function of melatonin MT(1) and MT(2) receptors in REM and NREM sleep","volume":"10","author":"Gobbi","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"29","key":"10.1016\/j.bcp.2026.117725_b0105","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0914-23.2024","article-title":"Selective enhancement of REM sleep in male rats through activation of melatonin MT(1) receptors located in the locus ceruleus norepinephrine neurons","volume":"44","author":"L\u00f3pez-Canul","year":"2024","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2026.117725_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102452","article-title":"Melatonin MT(1) and MT(2) receptors exhibit distinct effects in the modulation of body temperature across the light\/dark cycle","volume":"20","author":"L\u00f3pez-Canul","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117725_b0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2013.12.069","article-title":"Melatonin, selective and non-selective MT1\/MT2 receptors agonists: differential effects on the 24-h vigilance states","volume":"561","author":"Ochoa-Sanchez","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2026.117725_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106993","article-title":"Melatonin MT(1) receptors as a target for the psychopharmacology of bipolar disorder: a translational study","volume":"198","author":"Tassan Mazzocco","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12948","article-title":"Melatonin MT1 receptors regulate the Sirt1\/Nrf2\/Ho-1\/Gpx4 pathway to prevent \u03b1-synuclein-induced ferroptosis in Parkinson's disease","volume":"76","author":"Lv","year":"2024","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117725_b0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.arcmed.2019.08.005","article-title":"Reversal of Schizophrenia-like symptoms and cholinergic alterations bymelatonin","volume":"50","author":"Andrabi","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0135","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12674","article-title":"Melatonin recovers sleep phase delayed by MK-801 through the melatonin MT(2) receptor- Ca(2+) -CaMKII-CREB pathway in the ventrolateral preoptic nucleus","volume":"69","author":"Wang","year":"2020","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/rrlm-2017-0009","article-title":"Melatonin receptor 1B gene polymorphisms, haplotypes and susceptibility to schizophrenia","volume":"25","author":"Saravani","year":"2017","journal-title":"Revista Romana De Medicina De Laborator"},{"issue":"10","key":"10.1016\/j.bcp.2026.117725_b0145","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/cmdc.200900240","article-title":"N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands","volume":"4","author":"Rivara","year":"2009","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.j.pain.0000460311.71572.5f","article-title":"Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways","volume":"156","author":"Lopez-Canul","year":"2015","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0155","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00213-004-1944-1","article-title":"Bimodal effects of MK-801 on locomotion and stereotypy in C57BL\/6 mice","volume":"177","author":"Wu","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pnpbp.2012.07.003","article-title":"Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam","volume":"39","author":"Ochoa-Sanchez","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2026.117725_b0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejphar.2015.07.010","article-title":"Antinociceptive properties of selective MT(2) melatonin receptor partial agonists","volume":"764","author":"L\u00f3pez-Canul","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117725_b0170","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/biomedicines11061705","article-title":"Age-Related Effects of Exogenous Melatonin on Anxiety-like Behavior in C57\/B6J mice","volume":"11","author":"Nasini","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.bcp.2026.117725_b0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bph.15977","article-title":"Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome","volume":"180","author":"Inserra","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117725_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2026.117725_b0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-0716-2593-4_43","article-title":"Hypnotic effects of melatonergic compounds measured in mice or rats","volume":"2550","author":"Comai","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117725_b0190","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1096\/fasebj.12.12.1211","article-title":"Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms","volume":"12","author":"Dubocovich","year":"1998","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bcp.2026.117725_b0195","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jpi.12224","article-title":"Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain","volume":"58","author":"Lacoste","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2026.117725_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1001869","article-title":"Behavioral features and disorganization of oscillatory activity in C57BL\/6J mice after acute low dose MK-801 administration","volume":"16","author":"Cui","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2026.117725_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104625","article-title":"NMDA receptors on parvalbumin-positive interneurons and pyramidal neurons both contribute to MK-801 induced gamma oscillatory disturbances: complex relationships with behaviour","volume":"134","author":"Hudson","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.117725_b0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carl\u00e9n","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bcp.2026.117725_b0220","doi-asserted-by":"crossref","first-page":"e6755","DOI":"10.1371\/journal.pone.0006755","article-title":"NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness","volume":"4","author":"Hakami","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117725_b0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117725_b0230","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"50","key":"10.1016\/j.bcp.2026.117725_b0240","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1523\/JNEUROSCI.2676-11.2011","article-title":"Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand","volume":"31","author":"Ochoa-Sanchez","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0245","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41380-021-01316-6","article-title":"Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids","volume":"27","author":"Notaras","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bcp.2026.117725_b0250","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41380-024-02442-7","article-title":"Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA study","volume":"29","author":"Georgiadis","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"32","key":"10.1016\/j.bcp.2026.117725_b0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221533120","article-title":"Changes in patterns of age-related network connectivity are associated with risk for schizophrenia","volume":"120","author":"Passiatore","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0006-3223(89)90205-9","article-title":"Nocturnal plasma melatonin levels in schizophrenic patients","volume":"25","author":"Fanget","year":"1989","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0265","first-page":"137","article-title":"A study of light\/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia","volume":"22","author":"Vigan\u00f2","year":"2001","journal-title":"Neuro Endocrinol. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0270","first-page":"159","article-title":"Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics","volume":"36","author":"Monteleone","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bcp.2026.117725_b0275","doi-asserted-by":"crossref","first-page":"S452","DOI":"10.1016\/S0924-977X(10)70661-1","article-title":"Seasonality of serum melatonin concentrations in paranoid schizophrenic inpatients","volume":"20","author":"Mesa","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117725_b0280","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1096\/fasebj.10.8.8666165","article-title":"Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes","volume":"10","author":"Antol\u00edn","year":"1996","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117725_b0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000014569","article-title":"The oxidant\/antioxidant network: role of melatonin","volume":"8","author":"Reiter","year":"1999","journal-title":"Biol. Signals Recept."},{"issue":"1","key":"10.1016\/j.bcp.2026.117725_b0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0946-672X(03)80044-5","article-title":"Melatonin and pinoline prevent aluminium-induced lipid peroxidation in rat synaptosomes","volume":"17","author":"Mill\u00e1n-Plano","year":"2003","journal-title":"J. Trace Elem. Med Biol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117725_b0295","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09537100500128872","article-title":"Oxidative stress in blood platelets from schizophrenic patients","volume":"16","author":"Dietrich-Muszalska","year":"2005","journal-title":"Platelets"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117725_b0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.bcp.2026.117725_b0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/ijms12010401","article-title":"Study of OH radicals in human serum blood of healthy individuals and those with pathological schizophrenia","volume":"12","author":"Korotkova","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117725_b0310","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12653","article-title":"Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lackingmelatonin MT(2) receptors","volume":"69","author":"Comai","year":"2020","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0315","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu075","article-title":"Melancholic-like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice","volume":"18","author":"Comai","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117725_b0320","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70088","article-title":"Microglial Melatonin Receptor 1 Degrades Pathological Alpha-Synuclein through Activating LC3-Associated Phagocytosis InVitro","volume":"30","author":"Yao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.117725_b0325","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","article-title":"Sex differences in the risk of schizophrenia: evidence from meta-analysis","volume":"60","author":"Aleman","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0330","doi-asserted-by":"crossref","first-page":"178","DOI":"10.64719\/pb.4148","article-title":"Gender and schizophrenia","volume":"40","author":"Canuso","year":"2007","journal-title":"Psychopharmacol. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2026.117725_b0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/schbul\/16.2.319","article-title":"Gender differences in affective, schizoaffective, and schizophrenic disorders","volume":"16","author":"McGlashan","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0340","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0920-9964(90)90034-5","article-title":"Gender differences in affective, schizoaffective, and schizophrenic disorders","volume":"3","author":"Bardenstein","year":"1990","journal-title":"A Review. Schizophr Res"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2026.117725_b0345","doi-asserted-by":"crossref","first-page":"15602","DOI":"10.1073\/pnas.1010666108","article-title":"Sex difference in the near-24-hour intrinsic period of the human circadian timing system","volume":"108","author":"Duffy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bcp.2026.117725_b0350","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0748730410374943","article-title":"Sex differences in phase angle of entrainment and melatonin amplitude in humans","volume":"25","author":"Cain","year":"2010","journal-title":"J. Biol. Rhythms"},{"key":"10.1016\/j.bcp.2026.117725_b0355","article-title":"Intersection of sex and circadian biology","volume":"45","author":"Paschos","year":"2025","journal-title":"Curr. Opin. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117725_b0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(00)00491-X","article-title":"Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin","volume":"402","author":"Brotto","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117725_b0365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.yhbeh.2012.11.015","article-title":"Season- and context-dependent sex differences in melatonin receptor activity in a forebrain song control nucleus","volume":"63","author":"Bentley","year":"2013","journal-title":"Horm. Behav."},{"issue":"10","key":"10.1016\/j.bcp.2026.117725_b0370","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1176\/appi.ajp.2020.20070968","article-title":"Sleep Abnormalities in Schizophrenia: State of the Art and next steps","volume":"178","author":"Ferrarelli","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.bcp.2026.117725_b0375","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00702-012-0817-8","article-title":"Evaluating the links between schizophrenia and sleep and circadian rhythm disruption","volume":"119","author":"Pritchett","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.bcp.2026.117725_b0380","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acschemneuro.2c00592","article-title":"M(1)\/M(4)-preferring muscarinic cholinergic receptor agonist xanomeline reverses wake and arousal deficits in nonpathologically aged mice","volume":"14","author":"Russell","year":"2023","journal-title":"ACS Chem. Neurosci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:43:24Z","timestamp":1778057004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":76,"alternative-id":["S0006295226000560"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117725","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurophysiological and neuropharmacological effects of melatonin MT2 receptors activation in MK-801-induced schizophrenia-like dysfunctions","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117725"}}